<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862275</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.760</article-id><article-id pub-id-type="other">EPP0665</article-id><article-id pub-id-type="pii">S0924933824007600</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Fibronectin as a Marker of Myocardial Remodeling in Patients with Depression and Chronic Heart Failure</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Sikora</surname><given-names>A. K.</given-names></name><xref rid="aff1816" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0621" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fedorov</surname><given-names>S.</given-names></name><xref rid="aff1817" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1816"><sup>1</sup>Psychiatry, <institution>Narcology and Medical Psychology</institution></aff><aff id="aff1817"><sup>2</sup><institution>Ivano-FrankIskenderun National Medical University</institution>, <city>Ivano-Frankivsk
</city>, <country>Ukraine</country></aff><author-notes><corresp id="cor0621"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="735">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S370</fpage><lpage>S370</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824007600a.pdf"/><abstract><sec id="sec3733"><title>Introduction</title><p>
Depression is a significant issue in chronic heart failure (HF), with a prevalence of about 20&#x02013;40%, which is 4&#x02013;5% higher than in the general population (Mbakwem A., et al., 2016).</p></sec><sec id="sec3734"><title>Objectives</title><p>
The purpose of this study was to evaluate plasma fibronectin levels in patients with depression and chronic heart failure.</p></sec><sec id="sec3735"><title>Methods</title><p>
A total of 80 patients with HF II-III NYHA classes due to chronic coronary artery diseases (CAD) were observed. All patients were divided into two groups: Group 1 - 20 individuals without signs of depression, and Group 2 - 60 individuals with depression. The diagnosis of HF was confirmed based on ESC guidelines (2021). Depression was diagnosed using several questionnaires (Zung Self-Rating Depression Scale, Beck Depression Inventory, Hamilton&#x02019;s Depression Scale). Standard laboratory and instrumental tests were conducted. The plasma levels of fibronectin and interleukin-1&#x003b2; (IL-1&#x003b2;) were identified using ELISA methods. Statistical analyses were performed using Statistica system software, version 12.0.</p></sec><sec id="sec3736"><title>Results</title><p>The average plasma fibronectin concentration in patients with depression and HF was 1.24 times higher than a similar indicator in HF patients without depression: (259.63&#x000b1;5.71) &#x003bc;g/ml versus (203.41&#x000b1;9.51) &#x003bc;g/ml (p&#x0003c;0.05). The conducted correlation analysis indicated a moderate positive correlation between the level of fibronectin and the number of neutrophils in peripheral blood (r=0.35; p&#x0003c;0.05), the level of fibronectin and the magnitude of endogenous intoxication according to the erythrocyte absorption ability test (r=0.44; p&#x0003c;0.01), the level of fibronectin and IL-1&#x003b2; concentration (r=0.39; p&#x0003c;0.05), and an inverse correlation with left ventricle ejection fraction (r=0.32; p&#x0003c;0.05).</p></sec><sec id="sec3737"><title>Conclusions</title><p>Thus, the plasma fibronectin content in patients with depression and ischemic HF serves as a marker of the progression of myocardial remodeling processes and the intensity of the inflammatory process.</p></sec><sec id="sec3738"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>